DGX
Quest Diagnostics Incorporated · Healthcare · Medical - Diagnostics & Research
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -13.3% ·
Aktienfluss +2.5% ·
neue Nettopositionen -15.4%
— Formel
Konzentrierte Akkumulation — steigende Anteile bei weniger Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q4 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 154 | +1 | 78.04M | $16.53B | +7 | −6 |
| Q1 2026 | 156 | -1 | 76.50M | $14.98B | +4 | −6 |
| Q4 2025 | 156 | +4 | 87.42M | $15.15B | +5 | — |
| Q3 2025 | 16 | -1 | 54.97M | $10.47B | — | −2 |
| Q2 2025 | 15 | -3 | 44.54M | $8.00B | — | −3 |
| Q1 2025 | 15 | +2 | 17.80M | $3.01B | +3 | −1 |
| Q4 2024 | 13 | -2 | 18.37M | $2.77B | — | −2 |
| Q3 2024 | 14 | -1 | 12.70M | $1.97B | — | −1 |
| Q2 2024 | 15 | — | 9.75M | $1.33B | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 5.49M | +42.5% | $828.26M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 5.49M | +42.5% | $828.26M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passiv) | 5.22M | — | $787.72M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passiv) | 2.69M | +2.8% | $404.76M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passiv) | 2.69M | +2.8% | $404.76M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 1.78M | -23.5% | $269.16M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 1.78M | -23.5% | $269.16M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 1.78M | -23.5% | $269.16M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 1.78M | -23.5% | $269.16M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 1.78M | -23.5% | $269.16M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 1.78M | -23.5% | $269.16M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Norges Bank ✦ (passiv) | 1.27M | -1.8% | $191.82M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Marshall Wace ✦ | 796.08K | -20.4% | $120.10M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 14 | Marshall Wace ✦ | 796.08K | -20.4% | $120.10M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 15 | Marshall Wace ✦ | 796.08K | -20.4% | $120.10M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 16 | Millennium Management ✦ | 653.77K | +302.8% | $98.63M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 17 | Adage Capital Partners ✦ | 194.43K | -27.8% | $29.33M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 146.59K | -44.3% | $22.11M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 146.59K | -44.3% | $22.11M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 146.59K | -44.3% | $22.11M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 146.59K | -44.3% | $22.11M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 79.37K | +2570.6% | $11.97M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | Bridgewater Associates ✦ | 21.89K | -75.3% | $3.30M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | Two Sigma Investments ✦ | 21.89K | -0.7% | $3.30M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 25 | Gotham Asset Management ✦ | 1.34K | -28.1% | $202,303 | 0.0% | ▼ Trim | 3 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Citadel Advisors | $116.15M | war 0.1% |
| Renaissance Technologies | $5.92M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 1 Inhaber, 41.40K Anteile, $8,113 gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.